TIAN Hengli  

  • Chief Physician, Professor
  • Department: Neurosurgery
  • Research Area: Surgery (Neurosurgery)
  • Research Interests: Basic and clinical research of traumatic brain injury, cerebrovascular disease accident and neurocritical care
  • Contact: tianhlsh@126.com
  • Medical Doctoral Degree from Fudan University Shanghai Medical College, 2007
  • Master's Degree from Shanghai Jiao Tong University Shcool of Medicine, 1995
  • Bachelor's Degree in Clinical Medicine from Bengbu Medical College, 1986                                                                                
  • Director, Department of Neurosurgery, Shanghai Sixth People's Hospital                                                                                                   
  • Shanghai Leading Talents
  • Committee Member of the Neurosurgery Branch of Chinese Medical Association 
  •  Committee Member of Traumatology Branch of the Chinese Medical Association                                                                                    
  • Committee Member of World Federation of Neurosurgical Societies  
  • Standing Committee Member of Neural Injury Training Committee of Chinese Medical Doctor Association
  • Vice President of Neurosurgeon Branch of Shanghai Medical Doctor Association
  • Vice Chairman of Trauma Branch of Shanghai Medical Association
  1. Wang W#, Gong QY, Cai L, Jing Y, Yang DX, Yuan F, Chen H, Tian HL*. Knockout of Sirt2 alleviates traumatic brain injury in mice. Neural Regen Res, 2023, 18(2):350-356. doi: 10.4103/1673-5374.346457.
  2. Gong QY#, Cai L#, Jing Y, Wang W, Yang DX, Chen SW*, Tian HL*. Urolithin A alleviates blood-brain barrier disruption and attenuates neuronal apoptosis following traumatic brain injury in mice. Neural Regen Res, 2022, 17(9):2007-2013. doi: 10.4103/1673-5374.335163.
  3. Cai L#, Gong Q#, Qi L, Xu T, Suo Q, Li X, Wang W, Jing Y, Yang D, Xu Z, Yuan F, Tang Y, Yang G, Ding J*, Chen H*, Tian H*. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway. Cell Commun Signal, 2022, 20(1):56. doi: 10.1186/s12964-022-00862-y. 
  4. Jing Y#, Yang DX#, Wang W, Yuan F, Chen H, Ding J*, Geng Z*, Tian HL*. Aloin Protects Against Blood-Brain Barrier Damage After Traumatic Brain Injury in Mice. Neurosci Bull, 2020, 36(6): 625-638. doi: 10.1007/s12264-020-00471-0. 
  5. Yang DX#, Jing Y#, Liu YL, Xu ZM, Yuan F, Wang ML, Geng Z*, Tian HL*. Inhibition of Transient Receptor Potential Vanilloid 1 Attenuates Blood-Brain Barrier Disruption after Traumatic Brain Injury in Mice. J Neurotrauma, 2019, 36(8):1279-1290. doi: 10.1089/neu.2018.5942.
  6. Liu YL#, Yuan F#, Yang DX, Xu ZM, Jing Y, Yang GY, Geng Z*, Xia WL*, Tian HL*.  Adjudin Attenuates Cerebral Edema and Improves Neurological Function in Mice with Experimental Traumatic Brain Injury. J Neurotrauma, 2018, 35(23):2850-2860. doi: 10.1089/neu.2017.5397.
  7. Xu ZM#, Yuan F#, Liu YL, Ding J, Tian HL*. Glibenclamide Attenuates Blood-Brain Barrier Disruption in Adult Mice after Traumatic Brain Injury. J Neurotrauma, 2017, 34(4):925-933. doi: 10.1089/neu.2016.4491.
  8. Yuan F, Xu ZM, Lu LY, Nie H, Ding J, Ying WH, Tian HL. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation. J Neurochem, 2016, 136(3):581-93. doi: 10.1111/jnc.13423. 
  9. Yuan F#, Ding J, Chen H, Guo Y, Wang G, Gao WW, Chen SW, Tian HL*. Predicting progressive hemorrhagic injury after traumatic rain injury: derivation and validation of a risk score based on admission characteristics. J Neurotrauma, 2012, 29(12):2137-42. doi: 10.1089/neu.2011.2233.
  10. Yuan F#, Ding J, Chen H, Guo Y, Wang G, Gao WW, Chen SW, Tian HL*. Predicting outcomes after traumatic brain injury: the development and validation of prognostic models based on admission characteristics. J Trauma Acute Care Surg, 2012, 73(1):137-45. doi: 10.1097/TA.0b013e31824b00ac.
  1. [Hengli Tian, Lin Cai, Chunqi Tian, Qiuyuan Gong, Hao Chen, Fang Yuan, Jun Ding] (2023), “Application of Hanxiaolactone and its derivatives in the treatment of traumatic brain injury”, PCT/CN114010631B; ZL202111372558.9